Atlas Trials

Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy

Clinical trial NCT00530569 · UNKNOWN

Trial details

NCT number
NCT00530569
Sponsor
Alberta Health services
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2007-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.